CiVax™
Paper
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
COVID-19: Lai, C.Y., To, A., Wong, T.A.S., Lieberman, M.M., Clements, D.E., Senda, J.T., Ball, A.H., Pessaint, L., Andersen, H., Donini, O., Lehrer, A.T. Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice. 2021.
Publication
Frontiers in Immunity CoVaccine HT™ Publication
COVID-19: Haun, B.K., Lai, C.Y., Williams, C.A., Wong, T.A.S., Lieberman, M.M., Pessaint, L., Andersen, H., Lehrer, A.T. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. 2020.